Targeted Action: Its ability to localize in bones ensures targeted destruction of metastatic cancer cells. Pain Relief: Patients often experience significant pain relief due to the reduction in tumor burden. Improved Survival: Clinical trials have shown that radium 223 can extend overall survival in patients with CRPC. Minimal Side Effects: The short range of alpha particles means less damage to surrounding healthy tissues, resulting in fewer side effects compared to traditional radiotherapy.
